Podcasts October 8, 2024 Beyond traditional cancer care: how clinical trials save lives and money Clinical trials are revolutionizing cancer care by enhancing patient outcomes and reducing costs. In this episode of the Springbuk podcast, experts discuss how these trials provide crucial medical benefits and cost-effective solutions, … Read More
Webinar October 8, 2024 Understanding breast cancer from risk to recovery Watch our on-demand webinar to learn from PHM’s team of experts about the latest in breast cancer, including risk factors, screening tools, and treatments. Read More
Ask Our Experts October 8, 2024 New FDA rule requires breast density information in mammogram results Nearly half of women over 40 have dense breast tissue, which can make it more difficult to detect cancer by mammography and can increase breast cancer risk. As of September 2024, the … Read More
Case Studies October 8, 2024 Balancing quality of life and risk of breast cancer recurrence Many patients who have been diagnosed with early-stage cancer are faced with the daunting challenge of charting a treatment plan that maximizes recurrence prevention and considers side effects that could affect long-term … Read More
Ask Our Experts August 27, 2024 What to know about Stiff Person Syndrome, a rare autoimmune condition There are over 7,000 rare diseases that affect very small numbers of patients around the world. Due to the rarity of these conditions, it can be difficult to conduct the research needed to better understand them and to develop effective treatments. One rare disease that has recently come into the spotlight is called Stiff Person Syndrome (SPS). In 2022, global superstar Celine Dion revealed that she had been diagnosed with SPS, which had caused her to stop performing. This year, she released a documentary shedding light on her struggles with SPS symptoms and raising awareness. Read More
Case Studies August 15, 2024 How precision medicine and a life-saving clinical trial turned a grim prognosis into a cancer-free diagnosis When Peter*, an adventurous 60-year-old, was diagnosed with stage 2 esophageal cancer, he underwent standard treatment with chemotherapy, radiation, and surgery, and hoped that cancer was behind him. Unfortunately, his cancer recurred just five months later. Over the next three years, as his cancer spread to his liver and lungs. In the face of a grim prognosis, Peter’s refusal to give up led him to Private Health Management (PHM). Read More
